Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century
about
The potential for measles transmission in EnglandEstablishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of DjiboutiSeroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countriesEstimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models.Inferring infection hazard in wildlife populations by linking data across individual and population scales.Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models.Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivaxSerologically defined variations in malaria endemicity in Pará state, BrazilMumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines.Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among childrenA point-of-care test for measles diagnosis: detection of measles-specific IgM antibodies and viral nucleic acid.Oral fluid testing during 10 years of rubella elimination, England and Wales.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India.Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areasComparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.Towards elimination: measles susceptibility in Australia and 17 European countries.Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review.Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens.Is it appropriate to use fixed assay cut-offs for estimating seroprevalence?High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands.Re: Manikkavasagan G, Ramsay M. 2009. The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. Journal of Obstetrics and Gynaecology 29(7):574-577.Rubella seroprevalence in pregnant women in North Thames: estimates based on newborn screening samples.Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy?Estimating the population prevalence and force of infection directly from antibody titresAnalysis of rubella antibody distribution from newborn dried blood spots using finite mixture modelsLong-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university populationThe burden of parvovirus B19 infection in women of childbearing age in England and Wales
P2860
Q21257212-5715C3AE-C0F0-478E-91E1-591160ED9E9FQ24810344-1ED41DBD-7BEC-4C22-9F46-F89F8407C77FQ28078813-6A267FF9-6922-46DD-90BE-144842BE7327Q31043964-B60B62E4-12EF-466C-96CF-E45BDD022811Q31154831-8F85BA4E-E37B-4701-A597-8C330DF8C37AQ31158713-6F1B1ABA-1102-4519-8160-85D93BEB201EQ33533328-BF656C96-6303-440A-8553-45B1C345107DQ34565695-1AAA190D-CA11-41BE-8EC3-B4B90BE20B90Q34653218-19B0D14F-6428-48CA-A37E-4C79B045180AQ34794244-07BBD4A2-F9DE-4B5B-8003-B2AF5F176BB4Q35193389-28EA1857-1845-4339-A815-CDE94D18FF7BQ35804542-4ADF7A1C-F0CB-4898-B8C4-BB96C4A332ACQ36149754-3EDF385E-2ACF-4F0B-8C07-9DEDFAB5E761Q36153092-1763FADF-58B6-43CA-B75F-4B9416012051Q36249022-E8E32AE2-6F4D-4C4F-B5D8-8A2B7B77CCBAQ36252526-9565CC16-FCF9-40E6-9642-F08034FF5127Q36625461-E8B205EF-4708-4890-8156-14DFC2985FA6Q37108610-E0D6AC0D-4648-4F3A-BD81-F28F24E66D57Q37108714-3954507C-756A-4EA6-AF7E-1FF7720B195DQ37530327-B14F0B94-956C-439A-9BB9-185E110A8691Q37598130-6531F742-164A-42A3-AE93-B974B2D15C9EQ39339128-7AD02BB8-237B-4F40-B52F-DDE5C3D2978CQ40603758-93FFC715-76FD-4A11-A194-E4C09DE5E2CFQ42252439-1B5B3C7D-6AF9-42EA-8861-CBDF96798B89Q44958522-006C50BA-A776-48D1-8B22-C3A9B9EF7BD3Q46307994-02932A98-6CBF-4BA3-A7E3-24E61F7DD3E1Q47636789-59A1E366-BC96-4D76-9EE4-8A89858EBF63Q51122558-D101ED93-1899-401B-8218-1ACD68E03EE9Q56880798-0D79AE0D-325C-4C70-ABD0-441B46499BC1Q57076317-18E18071-26BB-47BC-AF47-FE9AE8ECEF71Q57100502-5187B824-ED75-4880-A32E-48D5A04F3827Q57385763-1A159DE4-1552-44F9-97B3-C6AE7894E225
P2860
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century
description
article
@en
im Dezember 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2006
@uk
name
Interpreting serological surve ...... beginning of the 21st century
@en
Interpreting serological surve ...... beginning of the 21st century
@nl
type
label
Interpreting serological surve ...... beginning of the 21st century
@en
Interpreting serological surve ...... beginning of the 21st century
@nl
prefLabel
Interpreting serological surve ...... beginning of the 21st century
@en
Interpreting serological surve ...... beginning of the 21st century
@nl
P2093
P2860
P1476
Interpreting serological surve ...... beginning of the 21st century
@en
P2093
L M Hesketh
P Morgan-Capner
P2860
P304
P356
10.1017/S0950268806006340
P407
P577
2006-12-01T00:00:00Z